Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22

医学 普拉格雷 替卡格雷 氯吡格雷 心房颤动 华法林 中止 阿司匹林 心肌梗塞 内科学 队列 冲程(发动机) 抗血栓 心脏病学 机械工程 工程类
作者
Claire T. Deakin,Juliana de Oliveira Costa,David Brieger,Jialing Lin,Andrea L. Schaffer,Michael Kidd,Sallie‐Anne Pearson,Michael O. Falster
出处
期刊:European Heart Journal - Quality of Care and Clinical Outcomes [Oxford University Press]
被引量:1
标识
DOI:10.1093/ehjqcco/qcae068
摘要

Abstract Background Dual antiplatelet therapy with P2Y12 inhibitors (P2Y12i) and aspirin following acute myocardial infarction (AMI) prevents future ischaemic events. People with atrial fibrillation (AF) also require oral anticoagulants (OAC), increasing bleeding risk. Guidelines recommend post-discharge prescribing of direct OAC with clopidogrel and discontinuation of P2Y12i after 12 months, but little is known about use in clinical practice. Aim To describe post-discharge use of OACs and P2Y12i in people with AF and a history of OAC use hospitalized for AMI. Methods and results We identified 1330 people hospitalized for AMI with a diagnosis of AF and history of OAC use in New South Wales, Australia, July 2018–June 2020. We identified three aspects of post-discharge antithrombotic medicine use with possible safety implications: (1) not being dispensed OACs; (2) dispensing OAC and P2Y12i combinations associated with increased bleeding (involving warfarin, ticagrelor, or prasugrel); and (3) P2Y12i use longer than 12 months. After discharge, 74.3% of people were dispensed an OAC, 45.4% were dispensed a P2Y12i, and 35.8% were dispensed both. People with comorbid heart failure or cancer were less likely to receive OACs. Only 11.2% of people who dispensed both an OAC and P2Y12i received combinations associated with increased bleeding; this was more common among people with chronic kidney disease or prior warfarin or statin use. A total of 44.6% of people dispensed both medicines continued P2Y12i for over 12 months; this was more common in people who received a revascularization or lived in areas of social disadvantage. Conclusion We identified potential gaps in pharmacotherapy, including underuse of recommended therapies at discharge, use of combinations associated with increased bleeding, and P2Y12i use beyond 12 months. Prescribing vigilance across both hospital and community care is required.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小徐完成签到,获得积分10
刚刚
1秒前
无奈冥完成签到,获得积分10
1秒前
1秒前
mm梦完成签到,获得积分10
1秒前
siyee完成签到,获得积分10
2秒前
2秒前
syr完成签到,获得积分10
2秒前
所所应助小邋遢采纳,获得10
2秒前
郝仇血完成签到,获得积分10
2秒前
ZzHappyOvO发布了新的文献求助10
2秒前
3秒前
斯文败类应助科研小南采纳,获得10
3秒前
bobo完成签到,获得积分10
3秒前
3秒前
3秒前
摆烂大王完成签到,获得积分10
3秒前
XJY发布了新的文献求助10
4秒前
Billie发布了新的文献求助30
4秒前
大知闲闲发布了新的文献求助10
4秒前
小鱼爱吃肉应助帅气老张采纳,获得10
4秒前
大象艾力分特应助11采纳,获得10
4秒前
运气爆彭完成签到,获得积分10
4秒前
骆欣怡发布了新的文献求助10
5秒前
白星星发布了新的文献求助10
5秒前
5秒前
小二郎应助Panjiao采纳,获得10
5秒前
可爱的函函应助暴发户采纳,获得10
5秒前
123123123发布了新的文献求助10
6秒前
2111355981发布了新的文献求助20
6秒前
苏沐阳完成签到,获得积分10
6秒前
白枫完成签到,获得积分10
6秒前
yxl发布了新的文献求助10
6秒前
在水一方应助愈好采纳,获得10
6秒前
7秒前
研友_VZG7GZ应助霍紫菡采纳,获得10
7秒前
11235应助xmhxpz采纳,获得10
7秒前
7秒前
柠木发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Principles of town planning: translating concepts to applications 1000
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
The Effective Clinical Neurologist 3ed 500
The Great Hymn to Šamaš 500
Moody's Ratings Rising AI spending narrows the gap, but US hyperscalers retain edge over Chinese peers 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7696747
求助须知:如何正确求助?哪些是违规求助? 9256795
关于积分的说明 20005185
捐赠科研通 7271220
什么是DOI,文献DOI怎么找? 3292836
关于科研通互助平台的介绍 2448408
邀请新用户注册赠送积分活动 2298634